1. Which pharmacy compounds it, and in which state is it licensed?
A 503A pharmacy is licensed and inspected by a state board of pharmacy. A provider that will not name the pharmacy is asking you to trust a link in the chain you cannot check.
What a “prescription peptide” actually is
Most of this site prices research chemicals, which are sold on a research-use attestation and are not medicines. A growing number of telehealth services offer the same compounds as compounded prescriptions instead. They are not the same thing, the difference is not mainly about price, and almost nobody explains it before asking for a card number.
No paid placements on this page
Nothing here is sponsored and no provider named on this page pays us anything. The most widely promoted provider in this category has no affiliate programme at all; where you see a discount code for one on another publisher’s site, that is a private arrangement rather than a programme anyone can join. See how this site makes money.
Three routes to the same molecule
The compound can be chemically identical across all three columns. What differs is who verified it, who is accountable, and what legal category you are standing in.
| Route | Regulatory review | Labelling | Identity assurance | Relative cost |
|---|---|---|---|---|
| FDA-approved productWegovy, Zepbound, Egrifta WR | Full new drug application reviewed by the FDA | Approved labelling with a studied amount, indication and contraindications | Manufacturer-attested and batch-traceable under FDA oversight | Highest |
| Compounded prescription, 503ACompounded semaglutide or tesamorelin via a telehealth intake | No FDA review of the compounded product itself | No approved labelling; the prescriber sets the amount | Pharmacy-attested; the pharmacy is licensed and inspected by the state | Middle |
| Research chemicalA vial from any vendor priced on this site | None | Sold for laboratory research use only, not for human use | Vendor-attested, typically via a certificate of analysis they commission | Lowest |
What 503A compounding does and does not mean
A 503A pharmacy compounds a medicine for an individual patient against a prescription. That is a real and long-standing part of medicine, and it is meaningfully more accountable than a research vial: a licensed pharmacy, a licensed prescriber, and a state board that can act on both.
What it does not mean is FDA review. The compounded product is not approved, has no approved labelling, and has not been evaluated for safety or effectiveness at the amount you are given. The amount is the prescriber’s judgement. For several compounds in this category there is no human trial for that judgement to rest on, which is the same gap the rest of this site documents, arriving by a different route.
The FDA also restricts which bulk substances may be compounded at all. Its Category 2 list names substances that may present significant safety risks; ipamorelin acetate is on the active list. Several other peptides sit on a withdrawn-nomination list, meaning nobody has successfully argued they belong in compounding. This is a moving picture, and the compliance centre tracks where each compound currently stands.
Five questions worth asking any provider
2. Is the prescribing clinician licensed in my state?
Telehealth prescribing is governed state by state. The provider's own physician being board certified somewhere is not the same as being licensed where you are.
3. Is this compound on the FDA's Category 2 list?
Category 2 names bulk drug substances the FDA considers may present significant safety risks, and they may not be used in 503A compounding. Ipamorelin acetate is on the active list. If a provider offers something on it, that is a question worth asking directly.
4. What happens to my intake data, and who else sees it?
A telehealth intake is a medical record. Ask what is retained, for how long, and whether it is shared with anyone for marketing.
5. What is the monthly commitment, and how do I stop?
Several providers price as a recurring protocol subscription rather than per vial. Find the cancellation terms before the first charge, not after.
Providers in this category
Listed because readers ask about them, described from their own published material, and ranked by nothing. This is not a recommendation and there is no commercial relationship behind it.
Beyond Whoosh
No affiliate programmeA telehealth service offering physician-prescribed peptide and GLP-1 protocols, compounded by licensed 503A pharmacies and shipped to the patient. The model is an online intake questionnaire, a review by a prescribing physician, and a recurring protocol rather than a per-vial purchase. Their published material describes monthly check-ins with the prescriber as part of the service, and medication supplied pre-reconstituted and cold-shipped. They operate a separately branded research storefront alongside the prescription service.
Read 2026-08-25 from their own site. Pricing is not published at the protocol level, so no figure appears here rather than an estimate.
The honest summary
A prescription route buys you accountability, not evidence. A licensed prescriber and a licensed pharmacy are real protections and they are worth something. They do not create a trial that does not exist, and they do not change the fact that for most compounds in this category the amount on the label is somebody’s judgement rather than somebody’s finding.
For the compounds where good evidence does exist, the incretins in particular, an approved product with approved labelling is the route with the most behind it. That is the least profitable sentence on this page and it is the correct one.